Neuro Centrum Science GmbH

Erbach im Odenwald 64711

0 studies enrolling now · 5 studies all time

What they study most

Alzheimer Disease, Early Alzheimer's Disease, Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting

Studies at this site

• A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE) — Completed
• A Study to Evaluate Efficacy, Safety, and Tolerability of EID of Natalizumab (BG00002) in Participants With RRMS Switching From Treatment With Natalizumab SID in Relation to Continued SID Treatment- Followed by Extension Study Comprising SC and IV Natalizumab Administration — Completed
• Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis — Status unconfirmed
• Effect of MD1003 in Progressive Multiple Sclerosis (SPI2) — Stopped early
• BI 409306 in Patients With Cognitive Impairment Due to Alzheimer's Disease. — Completed